Your browser doesn't support javascript.
loading
Migraine during COVID-19: Data from Second Wave Pandemic in an Italian Cohort.
Gentile, Eleonora; Delussi, Marianna; Abagnale, Chiara; Caponnetto, Valeria; De Cesaris, Francesco; Frattale, Ilaria; Guaschino, Elena; Marcinnò, Andrea; Ornello, Raffaele; Pistoia, Francesca; Putortì, Alessia; Candida, Giusy; Roveta, Fausto; Lupi, Chiara; Coppola, Gianluca; Prudenzano, Addolorata Maria Pia; Rainero, Innocenzo; Sances, Grazia; Roca, Maria Elena; Trojano, Maria; Pierelli, Francesco; Geppetti, Pierangelo; Sacco, Simona; de Tommaso, Marina.
Afiliação
  • Gentile E; Applied Neurophysiology and Pain Unit, SMBNOS Department, Bari Aldo Moro University, 70121 Bari, Italy.
  • Delussi M; Applied Neurophysiology and Pain Unit, SMBNOS Department, Bari Aldo Moro University, 70121 Bari, Italy.
  • Abagnale C; Headache Center, Sapienza Rome University, 04100 Latina, Italy.
  • Caponnetto V; Headache Regional Referral Center, ASL1 Abruzzo, L'Aquila University, 67100 L'Aquila, Italy.
  • De Cesaris F; Headache Center, Careggi General Hospital, 50139 Firenze, Italy.
  • Frattale I; Headache Regional Referral Center, ASL1 Abruzzo, L'Aquila University, 67100 L'Aquila, Italy.
  • Guaschino E; Headache Science Centre, IRCCS Mondino Foundation, 27100 Pavia, Italy.
  • Marcinnò A; Headache Center, Department of Neuroscience "Rita Levi Montalcini", University of Torino, 10124 Torino, Italy.
  • Ornello R; Headache Regional Referral Center, ASL1 Abruzzo, L'Aquila University, 67100 L'Aquila, Italy.
  • Pistoia F; Headache Regional Referral Center, ASL1 Abruzzo, L'Aquila University, 67100 L'Aquila, Italy.
  • Putortì A; Headache Science Centre, IRCCS Mondino Foundation, 27100 Pavia, Italy.
  • Candida G; Headache Center, Amaducci Neurological Clinic, Policlinico General Hospital, 70124 Bari, Italy.
  • Roveta F; Headache Center, Department of Neuroscience "Rita Levi Montalcini", University of Torino, 10124 Torino, Italy.
  • Lupi C; Headache Center, Careggi General Hospital, 50139 Firenze, Italy.
  • Coppola G; Headache Center, Sapienza Rome University, 04100 Latina, Italy.
  • Prudenzano AMP; Headache Center, Amaducci Neurological Clinic, Policlinico General Hospital, 70124 Bari, Italy.
  • Rainero I; Headache Center, Department of Neuroscience "Rita Levi Montalcini", University of Torino, 10124 Torino, Italy.
  • Sances G; Headache Science Centre, IRCCS Mondino Foundation, 27100 Pavia, Italy.
  • Roca ME; Headache Center, Amaducci Neurological Clinic, Policlinico General Hospital, 70124 Bari, Italy.
  • Trojano M; Headache Center, Amaducci Neurological Clinic, Policlinico General Hospital, 70124 Bari, Italy.
  • Pierelli F; Headache Center, Sapienza Rome University, 04100 Latina, Italy.
  • Geppetti P; Headache Center, Careggi General Hospital, 50139 Firenze, Italy.
  • Sacco S; Headache Regional Referral Center, ASL1 Abruzzo, L'Aquila University, 67100 L'Aquila, Italy.
  • de Tommaso M; Applied Neurophysiology and Pain Unit, SMBNOS Department, Bari Aldo Moro University, 70121 Bari, Italy.
Brain Sci ; 11(4)2021 Apr 10.
Article em En | MEDLINE | ID: mdl-33920175
OBJECTIVES: The study aims to assess the impact of the second COVID-19 pandemic wave on migraine characteristics. METHODS: This is an observational cross-sectional study conducted on migraine patients previously interviewed during the first Italian pandemic outbreak. A second structured telephone interview was conducted between 20 November 2020 and 18 January 2021. We compared migraine characteristics among T0 (before pandemic), T1 (during the first pandemic phase), and T2 (during the second pandemic phase). RESULTS: Among the 433 patients interviewed during the first pandemic phase, 304 cases were finally considered. One hundred forty-eight patients had a control visit between March 2020 and December 2020, 120 had an in-person visit, 14 by phone, the remainder used telemedicine software provided by the hospital. Frequency of headache, number of symptomatic drugs and headache intensity worsened during T2, compared to T0 and T1, especially in episodic migraine. Headache intensity increased relating to the negative emotional impact of the pandemic. Migraine management during the pandemic did not influence the clinical outcome. CONCLUSION: The prolongation of the pandemic seems to have a negative impact on migraine evolution. The arousal and negative psychological behavior toward the COVID-19 outbreak seem to worsen migraine.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Qualitative_research Idioma: En Revista: Brain Sci Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Qualitative_research Idioma: En Revista: Brain Sci Ano de publicação: 2021 Tipo de documento: Article